Generation of a New Humanized Pompe Disease Model for Improved Robust // Pre-Clinical Evaluation of new Pompe Therapeutics
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease.Autores: Chevet B, Devauchelle-Pensec V, Pontarini E, Baloche V, Bombardieri M, Bowman SJ, Barnes M, Sreih AG, Liu J, Kelly S, Christodoulou A, Moingeon P, Laigle L, Soret P, Le Dantec C, Pers JO, Alarcon-Riquelme ME, Barturen G, Mariette X, van Roon J, Seror R, Nocturne G, Cornec D, Foulquier N, PRECISEADS Clinical Consortium, NECESSITY consortium12/2025 - Annals of the rheumatic diseases
Nanomaterials-Enhanced Electrochemical Biosensors for Epithelial Cancer Diagnosis: Recent Advances.Autores: Regiart M, Gimenez AM, Ortega FG, Gómez GE, Sainz J, Tortella GR, Fernández-Baldo MA11/2025 - Biosensors
Cancer in a drop: Liquid biopsy highlights from the World Conference on Lung Cancer (WCLC) 2025.Autores: Ghazali N, Ortega-Franco A, de Miguel-Perez D, Saldanha EF, Venetis K, Pisapia P, Singhal S, Bleiberg BA, Reduzzi C, Borea R11/2025 - The journal of liquid biopsy